Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Altimmune, Amniox, Aobiome, Beyondspring, Blueprint, Can-Fite, Depuy, Exelixis, Galectin, Genmab, Humanigen, Impel, Inovio, Iveric, Marinus, Meissa, Nordic Nanovector, Novartis, Noxxon, Oncternal, Orexo, Orthocell, Reneuron, Revance, Rheacell, Roche, Rubius, Seattle Genetics, Zynerba.